A systematic review and meta‐analysis of ketamine in pediatric status epilepticus
Epilepsia · 2024-08 · 65 (8) · 2200-2212
DOI: 10.1111/epi.18035 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Epilepsia, online erschienen am 17.06.2024. Verfasst von Nicolas Chiriboga und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Intensive Care Unit Le Bonheur Children's Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Ketamine, Status Epilepticus. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Objective
Status epilepticus (SE) is a common neurological medical emergency in the pediatric population, with 10%–40% of cases progressing to refractory SE (RSE), requiring treatment with anesthetic infusions. We present a systematic review and meta‐analysis of the use of ketamine for the treatment of pediatric SE and its potential advantages over other anesthetic infusions.
Methods
This review follows the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) statement. Electronic databases, including PubMed, Cochrane Library, Ovid, Embase, and Google Scholar, were searched with the keywords “pediatrics,” “status epilepticus,” and “ketamine treatment.” Randomized trials, prospective and retrospective cohort studies, and case reports were considered for inclusion.
Results
Eighteen publications met the initial inclusion criteria. The 18 publications comprise 11 case reports, one nonconclusive clinical trial, two case series, and four retrospective cohorts. After excluding the case reports because of reporting bias, only the six case series and cohorts were included in the final analysis. There were 172 patients in the six included studies. The weighted age was 9.93 (SD = 10.29) years. The weighted maximum dose was 7.44 (SD = 9.39) mg/kg/h. SE cessation was attained in 51% (95% confidence interval = 43–59) of cases with the addition of ketamine. The heterogeneity was I 2 = 0%, t 2 = 0, χ 2 (5) = 3.39 ( p = .64). Significance Pediatric RSE is difficult to treat, resulting in increased morbidity and mortality. Without strong recommendations and evidence regarding preferred agents, this review provides evidence that ketamine may be considered in managing SE in the pediatric population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Intensive Care Unit Le Bonheur Children's Hospital, Memphis, Tennessee, USA.
- Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
- Department of Anatomy and Cell Biology, Rush Medical College, Chicago, Illinois, USA.
- Department of Pediatric Neurology, Rush University Children's Hospital, Chicago, Illinois, USA.
ORCID-Profile: Nicolas Chiriboga, Renad Abu-Sawwa
Zitieren
APA
Chiriboga, N., Spentzas, T., & Abu-Sawwa, R. (2024). A systematic review and meta‐analysis of ketamine in pediatric status epilepticus. Epilepsia, 65(8), 2200-2212. https://doi.org/10.1111/epi.18035
Vancouver
Chiriboga N, Spentzas T, Abu-Sawwa R. A systematic review and meta‐analysis of ketamine in pediatric status epilepticus. Epilepsia. 2024;65(8):2200-2212. doi:10.1111/epi.18035
BibTeX
@article{Chiriboga2024,
author = {Chiriboga, Nicolas and Spentzas, Thomas and Abu-Sawwa, Renad},
title = {A systematic review and meta‐analysis of ketamine in pediatric status epilepticus},
journal = {Epilepsia},
year = {2024},
volume = {65},
number = {8},
pages = {2200--2212},
doi = {10.1111/epi.18035}
}
EUVIMED